Mary A M Rogers1,2, M Todd Greene2,3,1, Jennifer A Davis2,3, David Ratz2,3,1, Latoya E Kuhn2,3, Sanjay Saint2,3,1, Vineet Chopra2,3,1. 1. Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA, 48109. 2. Department of Veterans Affairs, Ann Arbor Healthcare System and University of Michigan Patient Safety Enhancement Program, Ann Arbor, Michigan, USA. 3. Center for Clinical Management Research, VA Ann Arbor Healthcare System, Michigan, USA.
Abstract
OBJECTIVE: Although transfusion guidelines have changed considerably over the past two decades, the adoption of patient blood management programs has not been fully realized across hospitals in the United States. PATIENTS AND METHODS: We evaluated trends in red blood cell (RBC), platelet and plasma transfusion at three Veterans Health Administration (VHA) hospitals from 2000 through 2010. RESULTS: There were 176,521 hospitalizations in 69,621 patients; of these, 13.6% of hospitalizations involved transfusion of blood products (12.7% RBCs, 1.4% platelets, 3.0% plasma). Transfusion occurred in 25.2% of surgical and 5.3% of medical hospitalizations. Transfusion use peaked in 2002 for surgical hospitalizations and declined afterwards (p<0.001). There was no significant change in transfusion use over time (p=0.126) for medical hospitalizations. In hospitalizations that involved transfusions, there was a 20.3% reduction in the proportion of hospitalizations in which ≥3 units of RBCs were given (from 51.7% to 41.1%; p<0.001) and a 73.6% increase when one RBC unit was given (from 8.0% to 13.8%; p<0.001) from 2000-2010. Of the hospitalizations with RBC transfusion, 9.6% involved the use of one unit over the entire study period. The most common principal diagnoses for medical patients receiving transfusion were anemia, malignancy, heart failure, pneumonia and renal failure. Over time, transfusion utilization increased in patients who were admitted for infection (p=0.009). CONCLUSION: Blood transfusions in three VHA hospitals have decreased over time for surgical patients but remained the same for medical patients. Further study examining appropriateness of blood products in medical patients appears necessary.
OBJECTIVE: Although transfusion guidelines have changed considerably over the past two decades, the adoption of patient blood management programs has not been fully realized across hospitals in the United States. PATIENTS AND METHODS: We evaluated trends in red blood cell (RBC), platelet and plasma transfusion at three Veterans Health Administration (VHA) hospitals from 2000 through 2010. RESULTS: There were 176,521 hospitalizations in 69,621 patients; of these, 13.6% of hospitalizations involved transfusion of blood products (12.7% RBCs, 1.4% platelets, 3.0% plasma). Transfusion occurred in 25.2% of surgical and 5.3% of medical hospitalizations. Transfusion use peaked in 2002 for surgical hospitalizations and declined afterwards (p<0.001). There was no significant change in transfusion use over time (p=0.126) for medical hospitalizations. In hospitalizations that involved transfusions, there was a 20.3% reduction in the proportion of hospitalizations in which ≥3 units of RBCs were given (from 51.7% to 41.1%; p<0.001) and a 73.6% increase when one RBC unit was given (from 8.0% to 13.8%; p<0.001) from 2000-2010. Of the hospitalizations with RBC transfusion, 9.6% involved the use of one unit over the entire study period. The most common principal diagnoses for medical patients receiving transfusion were anemia, malignancy, heart failure, pneumonia and renal failure. Over time, transfusion utilization increased in patients who were admitted for infection (p=0.009). CONCLUSION: Blood transfusions in three VHA hospitals have decreased over time for surgical patients but remained the same for medical patients. Further study examining appropriateness of blood products in medical patients appears necessary.
Entities:
Keywords:
Veterans; plasma; platelets; red blood cells; transfusion
Authors: Patrick Meybohm; Eva Herrmann; Andrea U Steinbicker; Maria Wittmann; Matthias Gruenewald; Dania Fischer; Georg Baumgarten; Jochen Renner; Hugo K Van Aken; Christian F Weber; Markus M Mueller; Christof Geisen; Julia Rey; Dimitra Bon; Gudrun Hintereder; Suma Choorapoikayil; Johannes Oldenburg; Christian Brockmann; Raoul G Geissler; Erhard Seifried; Kai Zacharowski Journal: Ann Surg Date: 2016-08 Impact factor: 12.969
Authors: Jeffrey L Carson; Gordon Guyatt; Nancy M Heddle; Brenda J Grossman; Claudia S Cohn; Mark K Fung; Terry Gernsheimer; John B Holcomb; Lewis J Kaplan; Louis M Katz; Nikki Peterson; Glenn Ramsey; Sunil V Rao; John D Roback; Aryeh Shander; Aaron A R Tobian Journal: JAMA Date: 2016-11-15 Impact factor: 56.272
Authors: Mary A M Rogers; Neil Blumberg; Joanna M Heal; Latoya Kuhn; M Todd Greene; Emily Shuman; Carol E Chenoweth; Robert Chang; Sanjay Saint Journal: Arch Intern Med Date: 2011-09-26
Authors: Nareg H Roubinian; Gabriel J Escobar; Vincent Liu; Bix E Swain; Marla N Gardner; Patricia Kipnis; Darrell J Triulzi; Jerome L Gottschall; Yan Wu; Jeffrey L Carson; Steven H Kleinman; Edward L Murphy Journal: Transfusion Date: 2014-08-18 Impact factor: 3.157
Authors: Patrick Meybohm; Toby Richards; James Isbister; Axel Hofmann; Aryeh Shander; Lawrence Tim Goodnough; Manuel Muñoz; Hans Gombotz; Christian Friedrich Weber; Suma Choorapoikayil; Donat R Spahn; Kai Zacharowski Journal: Transfus Med Rev Date: 2016-05-28
Authors: Richard M Kaufman; Benjamin Djulbegovic; Terry Gernsheimer; Steven Kleinman; Alan T Tinmouth; Kelley E Capocelli; Mark D Cipolle; Claudia S Cohn; Mark K Fung; Brenda J Grossman; Paul D Mintz; Barbara A O'Malley; Deborah A Sesok-Pizzini; Aryeh Shander; Gary E Stack; Kathryn E Webert; Robert Weinstein; Babu G Welch; Glenn J Whitman; Edward C Wong; Aaron A R Tobian Journal: Ann Intern Med Date: 2015-02-03 Impact factor: 25.391
Authors: M Todd Greene; Sanjay Saint; David Ratz; Latoya Kuhn; Jennifer Davis; Payal K Patel; Mary A M Rogers Journal: Am J Infect Control Date: 2018-11-20 Impact factor: 2.918